|
RBM28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.7448E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.777600E-03 |
| Normal-vs-Stage2 |
1.595370E-01 |
| Normal-vs-Stage3 |
3.453900E-02 |
| Normal-vs-Stage4 |
5.513000E-01 |
| Stage1-vs-Stage2 |
4.909200E-01 |
| Stage1-vs-Stage3 |
8.689000E-01 |
| Stage1-vs-Stage4 |
5.191400E-01 |
| Stage2-vs-Stage3 |
5.474000E-01 |
| Stage2-vs-Stage4 |
3.379800E-01 |
| Stage3-vs-Stage4 |
4.685000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.004300E-04 |
| Normal-vs-AfricanAmerican |
3.387600E-02 |
| Normal-vs-Asian |
3.836000E-01 |
| Caucasian-vs-AfricanAmerican |
9.892800E-01 |
| Caucasian-vs-Asian |
9.745400E-01 |
| AfricanAmerican-vs-Asian |
9.794400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.222300E-03 |
| Normal-vs-Female |
1.016230E-04 |
| Male-vs-Female |
2.215900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.382200E-02 |
| Normal-vs-Extreme_Weight |
1.029560E-02 |
| Normal-vs-Obese |
1.220360E-02 |
| Normal-vs-Extreme_Obese |
1.991200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.490800E-01 |
| Normal_Weight-vs-Obese |
6.988400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.973000E-01 |
| Extreme_Weight-vs-Obese |
5.966400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.667400E-01 |
| Obese-vs-Extreme_Obese |
8.260000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.231730E-02 |
| Normal-vs-Age(41-60Yrs) |
2.07399999999636E-05 |
| Normal-vs-Age(61-80Yrs) |
1.119620E-02 |
| Normal-vs-Age(81-100Yrs) |
6.924800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.630200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.533000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.002200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.174590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.444970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.461200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.3863999999717E-06 |
| Normal-VS-Type2 PRCC |
4.414200E-01 |
| Normal-VS-KIRP CIMP |
9.985500E-02 |
| Normal-VS-Unclassified PRCC |
3.968400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.544700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.979200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.888000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.779600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.561780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.513800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.328000E-01 |
| Normal-vs-N1 |
5.265500E-02 |
| Normal-vs-N2 |
9.498400E-01 |
| N0-vs-N1 |
2.191600E-01 |
| N0-vs-N2 |
6.788400E-01 |
| N1-vs-N2 |
3.714200E-01 |
|
|
